Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006824
Filing Date
2005-03-16
Accepted
2005-03-16 17:30:22
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2153649z10-k.htm 10-K 1500355
2 EXHIBIT 10.42 a2153649zex-10_42.htm EX-10.42 47729
3 EXHIBIT 10.43 a2153649zex-10_43.htm EX-10.43 43475
4 EXHIBIT 10.44 a2153649zex-10_44.htm EX-10.44 34566
5 EXHIBIT 10.45 a2153649zex-10_45.htm EX-10.45 38375
6 EXHIBIT 21.1 a2153649zex-21_1.htm EX-21.1 15237
7 EXHIBIT 23.1 a2153649zex-23_1.htm EX-23.1 2255
8 EXHIBIT 31.1 a2153649zex-31_1.htm EX-31.1 5935
9 EXHIBIT 31.2 a2153649zex-31_2.htm EX-31.2 5936
10 EXHIBIT 32.1 a2153649zex-32_1.htm EX-32.1 4014
  Complete submission text file 0001047469-05-006824.txt   1700531
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16789 | Film No.: 05686705
SIC: 2835 In Vitro & In Vivo Diagnostic Substances